FIG 1.

Flow chart of participants showing prevalence of meropenem susceptibility and carbapenemase genes among Enterobacteriaceae isolates obtained from patients screened in the acute care hospital and intermediate- and long-term-care facilities. For ertapenem, resistant is defined as a MIC of ≥2 mg/liter, intermediate as 1 mg/liter, and susceptible as ≤0.5 mg/liter; for meropenem, resistant is defined as a MIC of ≥4 mg/liter, intermediate as 2 mg/liter, and susceptible as ≤1 mg/liter. Intermediate isolates were considered susceptible to carbapenems. ACH, acute-care hospital; ILTCFs, intermediate- and long-term-care facilities.